Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas

Medulloblastomas account for 20% of pediatric brain tumors. With an overall survival of 40%–70%, their treatment is still a challenge. The majority of medulloblastomas lack p53 mutations, but even in cancers retaining wild-type p53, the tumor surveillance function of p53 is inhibited by the oncoprot...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Künkele, Annette, De Preter, Katleen, Heukamp, Lukas, Thor, Theresa, Pajtler, Kristian W., Hartmann, Wolfgang, Mittelbronn, Michel, Grotzer, Michael A., Deubzer, Hedwig E., Speleman, Frank, Schramm, Alexander, Eggert, Angelika, Schulte, Johannes H.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2012
Предметы:
Basic and Translational Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3379802/
https://ncbi.nlm.nih.gov/pubmed/22591662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos115
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы